Shares of Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) have earned an average rating of “Hold” from the six brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have given a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $42.25.
A number of research firms recently commented on TRUP. Cantor Fitzgerald decreased their target price on Trupanion from $42.00 to $34.00 and set a “neutral” rating on the stock in a research report on Thursday, April 9th. Stifel Nicolaus decreased their target price on Trupanion from $35.00 to $31.00 and set a “hold” rating on the stock in a research report on Tuesday, March 31st. Weiss Ratings reiterated a “sell (d+)” rating on shares of Trupanion in a research report on Monday, June 1st. Finally, Bank of America decreased their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a research report on Tuesday, April 14th.
View Our Latest Research Report on Trupanion
Insider Buying and Selling at Trupanion
Institutional Investors Weigh In On Trupanion
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in TRUP. Parallel Advisors LLC raised its position in Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares during the period. Kemnay Advisory Services Inc. purchased a new stake in Trupanion during the fourth quarter valued at approximately $64,000. Kelleher Financial Advisors purchased a new stake in Trupanion during the third quarter valued at approximately $74,000. PNC Financial Services Group Inc. raised its position in Trupanion by 21.7% during the third quarter. PNC Financial Services Group Inc. now owns 2,678 shares of the financial services provider’s stock valued at $116,000 after purchasing an additional 478 shares during the period. Finally, Advisory Services Network LLC purchased a new stake in Trupanion during the third quarter valued at approximately $160,000.
Trupanion Price Performance
NASDAQ:TRUP opened at $23.54 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $1.03 billion, a P/E ratio of 39.90 and a beta of 1.45. Trupanion has a 12 month low of $21.16 and a 12 month high of $57.88. The business’s 50-day moving average is $24.07 and its 200 day moving average is $28.89.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.07 by $0.04. The company had revenue of $384.05 million for the quarter, compared to the consensus estimate of $379.77 million. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same period in the previous year, the business earned ($0.03) earnings per share. On average, equities research analysts forecast that Trupanion will post 0.53 earnings per share for the current fiscal year.
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Recommended Stories
- Five stocks we like better than Trupanion
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
